Newstral
Article
Forbes on 2024-03-27 22:58
InnovationRx: Base Editing Pioneer Nicole Gaudelli Joins GV
Related news
- NA step forward in DNA base editing news.harvard.edu
- A new tool for editing DNA, one base at a timeLA Times
- InnovationRx: #HealthcareIsHard; Plus Waning Covid Vaccine ImmunityForbes
- InnovationRx: Digital Health IPO DroughtForbes
- InnovationRx: New $217 Million Digital Health FundForbes
- InnovationRx: Opioid Overdose Deaths; Plus, ‘Stealth’ OmicronForbes
- InnovationRx: Power Women; Plus, Neutralizing OmicronForbes
- InnovationRx: Exploring The Future Of Healthcare AIForbes
- InnovationRx: FDA Approves Abbott’s Dissolvable StentsForbes
- Nicole GelinasNew York Post
- InnovationRx: Artificial Intelligence 50; Plus Covid Treatments In IndiaForbes
- InnovationRx: Lilly’s Alzheimer’s Drug Candidate Slows Cognitive Decline, Study SuggestsForbes
- CRISPR genome-editing pioneer to set up lab at Gladstonebizjournals.com
- InnovationRx: Who Do You Trust With Your Health Data?Forbes
- InnovationRx: Overdose Death High; Plus $100M For Doctor DataForbes
- InnovationRx: AI In Healthcare; Plus, Return Of The Mask?Forbes
- InnovationRx: Amwell’s $320 Million Acquisitions; Plus, Will Mask Mandates Help?Forbes
- InnovationRx: The Fall Equinox; Plus, U.S. Donates Covid-19 VaccinesForbes
- InnovationRx: Monkeypox Vaccine Rollout; Plus, Omicron-Specific BoostersForbes
- Editing Kevin DurantThe New Yorker